Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
Date:8/9/2011

D811.
  • Presented three posters of lorcaserin data from the Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) clinical trial at the American Diabetes Association's 71st Scientific Sessions.
  • Presented meta-analyses of the three trials in the lorcaserin Phase 3 clinical trial program - BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), BLOSSOM and BLOOM-DM - at ECO 2011, the 18th European Congress on Obesity.

    • Scheduled Financial Results Call Arena will host a conference call and webcast to discuss the second quarter 2011 financial results and to provide a business and financial update today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

    The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Second Quarter 2011 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

    Upcoming Corporate PresentationsArena is planning to present at upcoming conferences and meetings, including Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society, which is scheduled for October 1-5, 2011, in Orlando, Florida.

    About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inf
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
    2. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
    3. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
    4. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
    5. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
    6. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
    7. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
    9. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
    10. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
    11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... NEW YORK , May 23, 2013  Intercept ... clinical stage biopharmaceutical company focused on the development and ... liver diseases, such as primary biliary cirrhosis, today announced ... and Chief Executive Officer, will present at the Deutsche ... Boston on Wednesday, May 29, 2013 ...
    (Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
    (Date:5/23/2013)... -- MedVantx, Inc., the company that has pioneered a unique ... Company has completed a major expansion of its home ... the upgrade of its systems to offer a level ... home delivery pharmacy in Sioux Falls, SD ... health systems and payors novel distribution services, as well ...
    Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
    ... 7, 2012 CVS Caremark Corporation (NYSE: CVS ... a quarterly dividend of $0.1625 (16.25 cents) per share on ... to holders of record on April 23, 2012. ... Caremark CVS Caremark is the largest pharmacy ...
    ... SCOOTER Store , the nation,s leading provider of power ... File Development, was honored by a Department of Defense ... Reserve (ESGR), at a recent event held at company ... accepted the Patriot Award from Roland A. Keller, Ombudsman ...
    Cached Medicine Technology:The SCOOTER Store Employee Honored With Patriot Award 2
    (Date:5/23/2013)... Francisco (PRWEB) May 23, 2013 Pyramid ... and tumor registry services at the National Cancer ... June 2 at the Hilton Union Square in San ... issues to help cancer registrars keep up-to-date with changes ... offers cancer registry executives numerous opportunities to gain perspectives ...
    (Date:5/23/2013)... Ann Arbor, Mich. (PRWEB) May 23, 2013 ... the Ann Arbor creative firm was awarded a Silver ... category of Government Video. The winning entry was for ... was previously awarded “Best of Show” in the 2013 ... Flint metro regions. , The Summit Creative Award recognizes ...
    (Date:5/23/2013)... Platinum Supplemental Insurance recently promoted ... Satterlee started her Platinum sales career in 2011. Her ... team of sales representatives selling Platinum products. , Platinum ... residents of rural communities. Satterlee is in charge of ... is help farmers prepare for the future in the ...
    (Date:5/23/2013)... CA (PRWEB) May 23, 2013 Fresh ... provide vending machines stocked with healthy food and drinks ... country. The company’s in-house, full-service marketing and advertising department ... possible in the media for their franchisees, and to ... Vending has been featured in many leading publications and ...
    (Date:5/23/2013)... DC (PRWEB) May 23, 2013 Teen birth ... 2011, according to new data released today by ... time, the teen birth rate dropped at least 15% in ... , There were also dramatic declines among all racial/ethnic ... ,     Birth rates declined 40% or more for Hispanic ...
    Breaking Medicine News(10 mins):Health News:Pyramid Healthcare Solutions to Spotlight Its Cancer Registry Services at 2013 NCRA Conference 2Health News:Pyramid Healthcare Solutions to Spotlight Its Cancer Registry Services at 2013 NCRA Conference 3Health News:Platinum Supplemental Insurance Promotes Mary Satterlee to Sales Team Leader 2Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2
    ... wise not to drink the water. , Researchers from ... if their local water or air is contaminated with dangerous ... Andrew McKay, a PhD student at CRC CARE and The ... in a unique water microbe when it is exposed to ...
    ... Aug. 29, 2007 Michael Yarborough, a 58-year-old business ... three years ago revealed prostate cancer, but a side ... , After surgery to remove the cancer, I started ... company. Although my case was far better than most, ...
    ... Alcoholism a common trigger for downward social mobility, study ... alcoholism and living in a downscale neighborhood often go ... problem drinking that usually comes first. , "The more ... is going to remain in, or migrate into, a ...
    ... study finds , , TUESDAY, Aug. 28 (HealthDay News) -- Instead ... surgery -- both during and after the procedure. , According ... cancer surgery needed less anesthesia during the procedure, reported less ... had reduced costs. , "This helps women at a ...
    ... to describe the prevalence of HIV and Hepatitis B ... University of California, San Diego (UCSD) School of Medicine ... high-risk behavior could lead to an HIV epidemic in ... to reduce high-risk behaviors among injection drug users are ...
    ... researchers say , , TUESDAY, Aug. 28 (HealthDay News) -- ... sclerosis patients may help predict the severity of disease ... , "This is a new way to try to ... patient,s lesions," said lead researcher Dr. Rohit Bakshi, associate ...
    Cached Medicine News:Health News:Biosensors to probe the metals menace 2Health News:New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence 2Health News:Drinking Often Spurs Move to Poorer Neighborhoods 2Health News:Drinking Often Spurs Move to Poorer Neighborhoods 3Health News:Hypnosis Eases Pain of Breast Cancer Surgery 2Health News:Hypnosis Eases Pain of Breast Cancer Surgery 3Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 2Health News:High-risk behaviors could lead to HIV epidemic in Afghanistan 3Health News:Brain Lesions Predict MS Progression 2Health News:Brain Lesions Predict MS Progression 3
    ... The White Sun light source offers the industry ... Kelvin color temperature at a lower price. A ... White Sun to be used with Olympus, Storz, ... light output LED and re-settable bulb timer. The ...
    ... The NGAL ELISA Kit is intended for ... (e.g. plasma, serum, urine), tissue extracts or ... dramatically increased, especially in urine, as early ... in ongoing renal repair processes. NGAL expression ...
    ... Light Head is clearly the favorite for ... 36-inch arms, the dual light heads rotate ... stability, providing unlimited positioning. Engineered construction prevents ... ranging from minimally invasive through trauma to ...
    ... offers all the performance of a major surgical ... use in Outpatient Settings, Minor Procedure Rooms, C-Section, ... single lights either side of the OR table ... General OR when combining Flat Screen LCD Monitors ...
    Medicine Products: